Mabwell (shanghai) Bioscience Co., Ltd. Class ASSE: 688062

Announcement on Voluntary Disclosure of Clinical Trial Applications for 9MW5211 Injection Approved by China NMPA

· Issued by Mabwell (shanghai) Bioscience Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Clinical Trial Applications for 9MW5211 Injection Approved by China NMPA

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Mabwell (shanghai) Bioscience Co., Ltd. Class A

All Mabwell (shanghai) Bioscience Co., Ltd. Class A news releases